Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daridorexant in PTSD
NCT05948540Phase 2Suspended
- Sponsor
- Global Coalition for Adaptive Research
- Start
- Nov 2023
- Primary completion
- Apr 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of daridorexant in post-traumatic stress disorder (PTSD), sponsored by Global Coalition for Adaptive Research. Started Nov 2023; status: suspended.
02
Drugs
daridorexant
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT05948540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05948540.